When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BMY - VBL Therapeutics announces new study of VB-111 in CRC
Bristol-Myers Squibb Company
The National Cancer Institute (NCI) has launched a Phase 2 clinical trial evaluating the combination of VBL Therapeutics' (VBLT+2.6%) VB-111 (ofranergene obadenovec) and Bristol-Myers Squibb's (BMY-0.3%) Opdivo (nivolumab) in patients with metastatic colorectal cancer (CRC).
More news on: Vascular Biogenics Ltd., Bristol-Myers Squibb Company, Healthcare stocks news, Stocks on the move,